Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Does the $5 million+ to TPL appear in any PTSC PR or Q

"in excess of $5 Million"

"Based on the loans and concessions, and not including relieving TPL of it's obligation to maintain it's share of the $8 Million fund at the Joint Venture level, Patriot has made accomodations in the form of loans and other consideration to TPL totaling in excess of $5 Million."

From the Declaration of Gloria H. Felcyn, April 21, 2010

http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks_P/threadview?m=tm&bn=49226&tid=18201&mid=18201&tof=8&frt=2

Why is no one talking about this? Do you remember seeing anything from the BoD/Cliff about this? Certainly, it wasn't discussed at the shareholder meeting.

Share
New Message
Please login to post a reply